This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Johns Hopkins University. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New Delhi, IN (2014 - 2015)
- Towson, MD (US) (2016)
Company Filing History:
Years Active: 2014-2016
Title: Innovations by Srinivasa-Gopalan Sampathkumar
Introduction
Srinivasa-Gopalan Sampathkumar is a notable inventor based in New Delhi, India. He has made significant contributions to the field of therapeutic agents through his innovative research and development. With a total of 3 patents to his name, he has focused on creating hybrid molecules that have the potential to treat various diseases.
Latest Patents
Srinivasa-Gopalan Sampathkumar's latest patents include groundbreaking work on fatty acid carbohydrate hybrid molecules. One of his patents describes these compounds and their derivatives as therapeutic agents, detailing methods for treating or preventing diseases and their symptoms. Another patent focuses on hybrid short-chain fatty acid-hydroxyl-derivatized monosaccharides, outlining methods of synthesis and treatment for various disorders.
Career Highlights
Srinivasa-Gopalan Sampathkumar is affiliated with Johns Hopkins University, where he continues to advance his research in the field of therapeutic compounds. His work has garnered attention for its innovative approach to addressing health challenges through chemical synthesis and molecular design.
Collaborations
He has collaborated with esteemed colleagues such as Christopher Campbell and Kevin J Yarema, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Srinivasa-Gopalan Sampathkumar's contributions to the field of therapeutic agents through his patents and research at Johns Hopkins University highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
